Sitemap - 2025 - Signals From [Space]

Signals Brief: Should Primary Care Drive CKD Screening?

From Promise to Proof: AI-Designed Drugs Deliver, Xeno Workshop at MGH, Climate-Driven CKD Risks, & More

Signals Brief: Spend Now to Save Later? What We Know About The KCC Model’s Cost Curve and Future Direction

Signals Recap: A Week of Firsts — Kidney Disease Goes Global, Personalized CRISPR, MAHA's Report, CMS Targets MA, & more

Eugene Lin on how regulatory failures have crippled dialysis care: Signals KOLs

Signals Recap: Health Policy Shakeup—Medicaid Cuts, Drug Pricing Reform, FDA AI Strategy & CMMI's New Path

Wanted: Kidney Care Navigators

Signals Recap: Prioritizing Kidney Health on the World Stage and Here at Home

Signals Brief: What a Proposed $40B Cut to HHS Means for Kidney Care

Signals Recap: System Under Review—HHS, CMS & OPTN in Transition, Avalere's Latest CMMI Analysis, & More...

A Better Way to Find the Right People and Opportunities in Kidney Health

Update: Dialysis Decade: How New Devices Get To Market

Ben Hippen on IOTA, incentives, and how to build a transplant-inclusive kidney care model: Signals KOLs

Signals Recap: CMS Ends ETC, MedPAC Report, World Kidney Day, & More…

Signals Brief: CMS Shuts Down ETC—What's Next for Kidney Payments?

John Erbey on Targeting the Kidney’s Collecting System to Improve Fluid Removal & Sustain Function: Signals KOLs

John Erbey on the $650 billion kidney crisis and the problem no one seems to talking about: Signals KOLs

Signals Recap: Mass Layoffs at HHS & VA; NYT Investigates Transplant Chaos; FDA Fast-Tracks Kidney Cancer Drug & More…

Signals Brief: DaVita Earnings in Q4 2024

Signals Recap: Humana-Monogram, FDA Approves Xeno Trials, Travere Targets FSGS, National Donor Day, & More...

KCC in Numbers: What We Know, What We Don't, and What Comes Next

Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More...

Welcome to the Kidneyverse

Update: We should probably talk about barriers to home dialysis

Signals Recap: Azar on VBC, Carilion-UVa, TransMedics, JPM Takeaways, Ozempic, Vafseo, & More...

The State & Future of Nutrition in Kidney Health: Expert Q&A

Osman Khawar (Diality) on Moda-Flx and the need for more flexible dialysis treatment options: Signals KOLs

Signals Data Room: Key Metrics, Insights, & Analysis on Dialysis, Transplant, VBC, Devices, Diagnostics, Drugs & More

20 Things We Should Redesign in 2025 for a Healthier, More Secure World

Introducing: Transplant Databases